Sara Bonstein
About Sara Bonstein
Sara Bonstein is a seasoned finance executive with extensive experience in the biopharmaceutical sector, currently serving as CFO of Insmed since January 2020 and a board member at scPharmaceuticals Inc. since July 2020.
Chief Financial Officer at Insmed
Sara Bonstein has held the role of Chief Financial Officer (CFO) at Insmed, a biopharmaceutical company, since January 2020. In this capacity, she is responsible for overseeing the financial operations, which include financial planning, reporting, and risk management. Her financial stewardship supports the company’s mission to bring innovative therapies to patients with serious rare diseases.
Previous Leadership Roles at OncoSec Medical Incorporated
Before joining Insmed, Sara Bonstein served as the Chief Financial Officer (CFO) and Chief Operating Officer (COO) at OncoSec Medical Incorporated from May 2018 to January 2020. During her tenure, she managed the company's financial strategy and overall operations, playing a crucial role in its efforts to develop advanced cancer immunotherapies.
Tenure at Advaxis, Inc.
From February 2014 to April 2018, Sara Bonstein was the Chief Financial Officer, Treasurer, and Executive Vice President at Advaxis, Inc. Here, she was tasked with overseeing the company's financial health, managing investments, and ensuring the execution of its financial strategy. Advaxis focuses on the development of immunotherapies for cancer and infectious diseases.
Finance Roles at Major Companies
Sara Bonstein has a strong background in finance, having held various roles of increasing responsibility at Eli Lilly & Company, ImClone Systems, and Johnson & Johnson. Her experience includes significant financial oversight and strategic planning in some of the largest companies in the pharmaceutical and biotechnology sectors.
Board Member at scPharmaceuticals Inc.
Since July 2020, Sara Bonstein has been a member of the board of directors for scPharmaceuticals Inc. Her role includes providing strategic guidance and oversight to the company's senior management team as they work on creating transformative pharmaceutical products.
Educational Background
Sara Bonstein holds a Bachelor of Science degree in finance from The College of New Jersey and a Master of Business Administration (M.B.A.) degree from Rider University. Her formal education in finance and business administration forms the foundation of her expertise in financial management and strategy development.